Sage Journals: Discover world-class research

Free access

Research article

First published 2013-10

Management of hypertension with fixed-dose triple-combination treatments

Benjamin J. Epstein, Niren K. Shah, Nancy L. Borja-Hart

Therapeutic Advances in Cardiovascular Disease

Open access

Review article

First published 2019

Triple therapy for COPD: a crude analysis from a systematic review of the evidence

Jose Luis Lopez-Campos, Laura Carrasco-Hernandez, Esther Quintana-Gallego [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2022

Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution

Fulvio Braido, Angelo G. Corsico, Davide Paleari [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2012-7

Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease

Michel Farnier, Kjetil Retterstøl, Armin Steinmetz [...]

Diabetes & Vascular Disease Research

Retricted access

Review article

First published 2022-5

Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease

Stefanie C. Nigro, Diana M. Sobieraj

Annals of Pharmacotherapy

Retricted access

Review article

First published 2019-8

Dolutegravir-Rilpivirine,Dual Antiretroviral Therapy for the Treatment of HIV-1 Infection

E. Kelly Hester, Kevin Astle

Annals of Pharmacotherapy

Retricted access

Review article

First published 2018-1

Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes

Valerie Azzopardi Coppenrath, Tasmina Hydery

Annals of Pharmacotherapy

Open access

Review article

First published 2018

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate,umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Mario Malerba, Matteo Nardin, Giuseppe Santini [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

José M. Marín, Luis Mateos, Juan Roldán [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2023

Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease

Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo [...]

Therapeutic Advances in Respiratory Disease

Search results